Nafarelin for endometriosis: a large-scale, danazol-controlled trial of efficacy and safety, with 1-year follow-up
article
OA: closed
CC0
⤵ 65 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
This trial compared the efficacy and safety of nafarelin to danazol for endometriosis treatment, with follow-up extending to one year.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (11)
- Administration of Nasal Nafarelin as Compared with Oral Danazol for Endometriosis via openalex
- Clinical experience treating endometriosis with nafarelin. via openalex
- DANAZOL AND LIVER DAMAGE via openalex
- Evidence of similar increases in bone turnover during nafarelin and danazol use in women with endometriosis via openalex
- Gonadotropin-Releasing Hormone (GnRH) Agonists in the Management of Endometriosis: A Review via openalex
- Metabolic changes during medical treatment of endometriosis: Nafarelin acetate versus danazol via openalex
- W2477008945 via openalex
- W2031495520 via openalex
- W2037690190 via openalex
- W2129449855 via openalex
- W2416779647 via openalex
Cited by (50)
- A systematic literature review on patient-reported outcome domains and measures in nonsurgical efficacy trials related to chronic pain associated with endometriosis: an urgent call to action 2024
- Gonadotropin-releasing hormone analogues for endometriosis 2023
- GnRH agonists in the treatment of symptomatic endometriosis: a review 2022
- Endometriosis 2021
- Heavy menstrual bleeding diagnosis and medical management 2017
- Reevaluating response and failure of medical treatment of endometriosis: a systematic review 2017
- “Per vaginam” topical use of hormonal drugs in women with symptomatic deep endometriosis: a narrative literature review 2017
- Analogs of Luteinizing Hormone-Releasing Hormone in the Treatment of Endometriosis 2015
- Integrated Pharmacometrics and Systems Pharmacology Model‐Based Analyses to Guide GnRH Receptor Modulator Development for Management of Endometriosis 2012
- Endometriosis 2012
- Gonadotrophin-releasing hormone analogues for pain associated with endometriosis 2010
- Current pharmacotherapy for endometriosis 2010
- Traitements des localisations urologiques de l'endométriose 2009
- Efficacy of vaginal danazol treatment in women with menorrhagia during fertile age 2008
- Gonadotropin-Releasing Hormone Agonists for Endometriosis 2008
- Endometriosis 2008
- Ovulation suppression for endometriosis for women with subfertility 2007
- Endometriosis 2007
- GnRH analogs: Options for endometriosis-associated pain treatment 2006
- Management of the Pain Associated with Endometriosis: An Update of the Painful Problems 2006
- Abnormal Uterine Bleeding: Medical Treatment with Vaginal Danazol and Five-Year Follow-up 2004
- Optimizing Gonadotropin-Releasing Hormone Agonist Therapy in Women with Endometriosis 2004
- Tratamiento de la endometriosis y medicina basada en la evidencia 2003
- Medical Therapy for Endometriosis 2003
- Adolescent Endometriosis 2003
- Ovulation suppression for endometriosis 2003
- The Treatment of Endometriosis 2002
- Prolonged GnRH Agonist and Add-Back Therapy for Symptomatic Endometriosis 2002
- Consensus statement for the management of chronic pelvic pain and endometriosis: proceedings of an expert-panel consensus process 2002
- Treatment of Endometriosis 2001
- Changes in quality of life after hormonal treatment of endometriosis 2001
- Prospective randomized study comparing the GnRH-agonist leuprorelin acetate and the gestagen lynestrenol in the treatment of severe endometriosis 2001
- Medical and Surgical Therapies for Pain Associated with Endometriosis 2001
- Estroprogestin vs. gonadotrophin agonists plus estroprogestin in the treatment of endometriosis-related pelvic pain: a randomized trial 2000
- Managing endometriosis 2000
- Gonadotrophin-releasing hormone analogues for pain associated with endometriosis 1999
- Combined Medical and Surgical Treatment of Women with Endometriosis 1999
- Today's treatments: how do you choose? 1999
- Ultrasound guided aspiration of endometrioma — a new therapeutic modality to improve reproductive outcome 1999
- Medical Treatment of Endometriosis-Associated Pain 1999
- The evidence for the management of endometriosis 1998
- Cost comparisons between nafarelin and leuprolide in the treatment of endometriosis 1998
- Pre or post-operative medical treatment with nafarelin in stage III–IV endometriosis: a French multicenter study 1998
- MODERN MEDICAL MANAGEMENT OF ENDOMETRIOSIS 1997
- The role of laparoscopy in the management of pelvic pain in women of reproductive age 1997
- A double-blind randomized study of the treatment of endometriosis with nafarelin or nafarelin plus norethisterone 1997
- Goserelin Depot Versus Danazol in the Treatment of Endometriosis The Australian/New Zealand Experience* 1996
- Effects of a gonadotropin-releasing hormone agonist on the calcium-parathyroid axis and bone turnover in women with endometriosis 1995
- Gynecology 1995
- Recurrent Endometriosis 1995
Source provenance
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- unpaywall
- last seen: 2026-06-04T02:00:05.705006+00:00
License: CC0
· commercial use OK